• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC DIMENSION VISTA; DIMENSION VISTA ® COV2T SARS-COV-2 TOTAL ANTIBODY ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC DIMENSION VISTA; DIMENSION VISTA ® COV2T SARS-COV-2 TOTAL ANTIBODY ASSAY Back to Search Results
Catalog Number K7414 SMN 11417414
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/20/2021
Event Type  malfunction  
Manufacturer Narrative
The customer contacted the siemens customer care center regarding a positive dimension sars-cov-2 total antibody (cov2t) patient sample result obtained on a dimension vista 1500 system.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).Siemens is investigating the event.
 
Event Description
The customer considered a positive dimension vista sars-cov-2 total antibody (cov2t) result on a patient sample processed on a dimension vista 1500 system to be discordant.The patient result was reported to the physician.The same patient sample was processed on a non-siemens instrument system using an immunglobulin g (igg) methodology.A negative result was obtained.There are no known reports of patient intervention or adverse health consequences due to the discordant dimension vista cov2t patient result.
 
Manufacturer Narrative
Initial mdr 2517506-2021-00116 was filed 14-may-2021.Additional information (19-may-2021): siemens healthcare diagnostics headquarters support center (hsc) concluded the investigation of the event.Hsc has reviewed the instrument data.No product non-conformance was identified with the assay or the analyzer.The event involved a patient sample which reported a result of positive using the dimension vista sars-cov-2 total antibody (cov2t) assay.The customer repeated the same sample using a non-siemens sars-cov-2 igg antibody assay and the result was reported as negative.The calibration and quality control (qc) for the dimension vista cov2t assay were within acceptance limits at the time of the event and there were no process errors indicating both the assay and the instrument were operating within specifications.The dimension vista cov2t assay is a qualitative assay for detection of the presence of igg and igm antibodies to the sars-cov-2 s1 rbd protein.The non-siemens assay is a qualitative assay for detection of the presence of igg antibodies to the sars-cov-2 s1 rbd protein.The patient sample was not repeated on the dimension vista and the customer states there is no sample left for further testing.The patient had previously been infected with the sars-cov-2 virus 8 months prior, so the dimension vista assay result is consistent with patient history.Hsc cannot rule out that the positive cov2t result is not from a mixture of igm and igg antibodies while the concentration of only the igg antibodies was not high enough to trigger a positive result with the non-siemens sars-cov-2 igg assay.There is no claim of correlation between the dimension vista cov2t assay and the non-siemens sars-cov-2 igg assay.The discordance between the two assays may be tied to patient specific differences.The cause of the discrepancy is unknown.The device is performing within specifications.No further evaluation is required.Although there is no potential for serious injury in this case, an mdr was reported to the fda as a requirement of the emergency use authorization (eua).Section h6 has been updated to reflect the hsc investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIMENSION VISTA
Type of Device
DIMENSION VISTA ® COV2T SARS-COV-2 TOTAL ANTIBODY ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC
500 gbc drive
po box 6101
newark DE 19714 6101
MDR Report Key11824527
MDR Text Key251214746
Report Number2517506-2021-00116
Device Sequence Number1
Product Code QKO
UDI-Device Identifier00630414605500
UDI-Public00630414605500
Combination Product (y/n)N
PMA/PMN Number
EUA201459
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 05/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/14/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/10/2021
Device Catalogue NumberK7414 SMN 11417414
Device Lot Number20349BD
Was Device Available for Evaluation? No
Date Manufacturer Received05/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-